The development and validation of alternatives to animal testing has accelerated dramatically through organ-on-a-chip technology, organoids, computational modelling and high-throughput screening, transforming what is achievable without animals.
Key Facts
The European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM) validates and promotes alternative methods
Organ-on-a-chip devices replicate human organ physiology more accurately than many animal models for some applications
Organoids — three-dimensional tissue models grown from stem cells — can model human disease in ways that animal models cannot
In silico modelling using computer algorithms can predict toxicity and drug activity for millions of compounds simultaneously
The US National Toxicology Program has committed to eliminating animal testing in regulatory toxicology where validated alternatives exist
Welfare Considerations
The progress of animal testing alternatives represents one of the most welfare-positive scientific trends of recent decades. Each validated alternative method that replaces an animal model eliminates not just the animals used in the validated study but all future uses of that animal model in similar applications. The welfare cumulative benefit of alternative methods development is therefore enormous over time. Human-relevant results are an additional benefit — organ-on-a-chip and organoid models of human tissue may predict human responses more accurately than rodent models in many applications, making welfare improvement and scientific progress complementary rather than competing goals.
What You Can Do
Support NC3Rs and EURL ECVAM funding for alternatives development and validation
Advocate for pharmaceutical and cosmetics companies to publish their alternative methods adoption timelines
Engage with university research ethics committees about Three Rs implementation in research applications
Follow alternatives development progress through journals such as Alternatives to Laboratory Animals
Support regulatory agencies in adopting validated alternative methods through public consultation submissions